Blood volume and brain natriuretic peptide in congestive heart failure: A pilot study

James, Karen B.; Troughton, Richard W.; Feldschuh, Joseph; Soltis, Daniel; Thomas, D.; Fouad‐Tarazi, Fetnat M.

doi:10.1016/j.ahj.2005.07.031

Cited by 46 publications

(39 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A small pilot study by James et al, looked at blood volume and BNP values for ten CHF patients with pulmonary catheterization. The patients had an expanded blood volume approximately 30 % more than baseline [12]. The pre-treatment and post-treatment BNP had poor correlation with blood volume (correlation factor r = -0.127 and -0.126, respectively) [12].…”

Section: Natriuretic Peptidesmentioning

confidence: 99%

Fluid-Volume Assessment in the Investigation of Acute Heart Failure

Tuy

Than

2013

Curr Emerg Hosp Med Rep

View full text Add to dashboard Cite

Heart failure is a syndrome whereby cardiac function is incapable of providing for the body's circulatory demands, resulting in hemodynamic and volumetric aberrations. Acute heart failure (AHF) is the condition where signs and symptoms of heart failure are present that require urgent intervention. In AHF impaired cardiac function progresses to hemodynamic congestion and eventually develops into a fluid overloaded state. These patients will typically present acutely for medical assistance, with signs and symptoms of fluid overload (dyspnea, paroxysmal nocturnal dyspnea, orthopnea, edema, etc.) and/or hypoperfusion (malaise, altered mental status, decreased urine output). In patients with AHF, volume assessment is a crucial step in the initial diagnosis.

show abstract

Section: Natriuretic Peptidesmentioning

confidence: 99%

Fluid-Volume Assessment in the Investigation of Acute Heart Failure

Tuy

Than

2013

Curr Emerg Hosp Med Rep

View full text Add to dashboard Cite

show abstract

“…1 Second, Mueller et al 16 characterized daily dyspnea, edema, and correlated better with changes in blood volume than with changes in BNP values. Although the sample size was small, the researchers 26 thought that BNP values changed more slowly than did blood volume and were better for showing longterm rather than instantaneous volume status.…”

Section: Assessment Of Hypervolemiamentioning

confidence: 99%

“…In one study, 25 levels of BNP increased with worsening heart failure and correlated with New York Heart Association functional class. However, in another study, 26 after treatment, patients' hemodynamic parameters damage of cardiac myocytes, and minimization of preventable recurrences of hypervolemia that require hospitalization for heart failure decompensation. 1,28 In patients with hypervolemia, signs and symptoms are the tip of the iceberg in regard to congestion.…”

Section: Fluid Management Strategiesmentioning

confidence: 99%

“…26,[55][56][57][58] • Carefully assess patient's rationale for nonadherence. Consider economic issues (transportation or costs of care), social issues (caregiver support, loneliness), 57 psychological issues (depression, anxiety), 58 and cognition issues.…”

Section: Issuementioning

confidence: 99%

“…(Critical Care Nurse. 2012;32 [2]: [20][21][22][23][24][25][26][27][28][29][30][31][32]34) cardiac output, arterial underfilling, activation of neurohormonal systems, and dysregulation between the heart and kidneys. 4 Two large US heart failure registries, Acute Decompensated Heart Failure Registry (ADHERE) 5 and Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) 6 collected data on the clinical features of patients hospitalized for acute decompensated heart failure.…”

Section: Patientsmentioning

confidence: 99%

See 2 more Smart Citations

Fluid Management Strategies in Heart Failure

Albert

2012

Critical Care Nurse

View full text Add to dashboard Cite

In patients with chronic heart failure, fluid retention (or hypervolemia) is often the stimulus for acute decompensated heart failure that requires hospitalization. The pathophysiology of fluid retention is complex and involves both hemodynamic and clinical congestion. Signs and symptoms of both hemodynamic and clinical congestion should be assessed serially during hospitalization. Core heart failure drug and cardiac device therapies should be provided, and ultrafiltration may be warranted. Critical care, intermediate care, and telemetry nurses have roles in both assessment and management of patients hospitalized with acute decompensated heart failure and fluid retention. Nurse administrators and managers have heightened their attention to fluid retention because the Medicare performance measure known as the risk-standardized 30-day all-cause readmission rate after heart failure hospitalization can be attenuated by fluid management strategies initiated by nurses during a patient’s hospitalization.

show abstract

Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations

Müeller

McDonald

Boer

et al. 2019

European J of Heart Fail

564

473

View full text Add to dashboard Cite

Natriuretic peptide [NP; B-type NP (BNP), N-terminal proBNP (NT-proBNP), and midregional proANP (MR-proANP)] concentrations are quantitative plasma biomarkers for the presence and severity of haemodynamic cardiac stress and heart failure (HF). End-diastolic wall stress, intracardiac filling pressures, and intracardiac volumes seem to be the dominant triggers. This paper details the most important indications for NPs and highlights 11 key principles underlying their clinical use shown below.(i) NPs should always be used in conjunction with all other clinical information.(ii) NPs are reasonable surrogates for intracardiac volumes and filling pressures. (iii) NPs should be measured in all patients presenting with symptoms suggestive of HF such as dyspnoea and/or fatigue, as their use facilitates the early diagnosis and risk stratification of HF. (iv) NPs have very high diagnostic accuracy in discriminating HF from other causes of dyspnoea: the higher the NP, the higher the likelihood that dyspnoea is caused by HF. (v) Optimal NP cut-off concentrations for the diagnosis of acute HF (very high filling pressures) in patients presenting to the emergency department with acute dyspnoea are higher compared with those used in the diagnosis of chronic HF in patients with dyspnoea on exertion (mild increase in filling pressures at rest). (vi) Obese patients have lower NP concentrations, mandating the use of lower cut-off concentrations (about 50% lower). (vii) In stable HF patients, but also in patients with other cardiac disorders such as myocardial infarction, valvular heart disease, atrial fibrillation or pulmonary embolism, NP concentrations have high prognostic accuracy for death and HF hospitalization.

show abstract

Blood volume and brain natriuretic peptide in congestive heart failure: A pilot study

Cited by 46 publications

References 18 publications

Fluid-Volume Assessment in the Investigation of Acute Heart Failure

Fluid-Volume Assessment in the Investigation of Acute Heart Failure

Fluid Management Strategies in Heart Failure

Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations

Contact Info

Product

Resources

About